Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Yes, fluoxetine can cause serotonin syndrome, most often when combined with other serotonergic drugs such as triptans, tramadol, MAOIs, lithium, or St. John's wort, producing agitation, rapid heart rate, sweating, tremor, muscle rigidity, and fever that require urgent care. It also carries a boxed warning for increased suicidal thoughts and behaviors, particularly in children, teens, and adults under 25, and especially during the first few weeks of treatment or after a dose change. Warning signs include new or worsening anxiety, agitation, restlessness, insomnia, irritability, or talk of self-harm, and these need same-day medical attention. Both risks are uncommon but serious, and several factors influence your personal risk, including dose, drug interactions, and how recently treatment started, so see below to understand more.
If you are noticing new agitation, fever, muscle twitching, mood changes, or darker thoughts while taking fluoxetine, sorting urgent from expected side effects quickly matters. A free, instant, online symptom check can help you organize your symptoms, gauge how concerning they are, and decide whether to call your prescriber, seek emergency care, or monitor at home, so you walk into your next conversation with clear answers instead of guesswork.
Last reviewed for medical accuracy: 09/13/2026
Fluoxetine is a commonly prescribed antidepressant in the selective serotonin reuptake inhibitor (SSRI) class. While generally safe and effective, understanding serious fluoxetine side effects—like serotonin syndrome and changes in suicidal thinking—is important for anyone taking this medication.
Fluoxetine (brand name Prozac) treats depression, anxiety, obsessive-compulsive disorder, bulimia nervosa and other conditions. It works by:
Because fluoxetine alters serotonin levels, it can—rarely—trigger excessive serotonin activity or affect suicidal thoughts, especially early in treatment.
Serotonin syndrome is a potentially life-threatening condition caused by too much serotonin in the body. It’s most likely when fluoxetine is combined with other drugs that also boost serotonin, such as:
Symptoms usually appear within hours of a dosage increase or drug combination. Look out for:
If you notice any of these, seek medical help immediately. Serotonin syndrome can progress rapidly and requires prompt treatment.
All antidepressants carry a “black box” warning from the U.S. Food and Drug Administration (FDA) about an increased risk of suicidal thinking or behavior in children, adolescents and young adults (up to age 24). Key points:
Fluoxetine side effects vary widely by individual. Common side effects (often mild and improving over time) include:
Rare but serious side effects include:
Before you start or stop fluoxetine:
Always follow your doctor’s guidance on dosing schedules. Do not stop fluoxetine abruptly, as withdrawal symptoms (dizziness, mood swings, irritability) can occur.
If you experience any life-threatening or serious signs—such as fever with muscle stiffness, severe agitation, or thoughts of harming yourself—seek medical attention right away. For less urgent concerns, you can consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
To lower the chance of serious fluoxetine side effects:
Fluoxetine can be a highly effective antidepressant. While rare, serotonin syndrome and increased suicidal thoughts—especially in younger patients—are serious risks to be aware of. By staying informed, monitoring symptoms and working closely with your healthcare team, you can manage fluoxetine side effects safely.
If you ever experience symptoms that feel life-threatening or serious, speak to a doctor or go to the nearest emergency department immediately. For non-urgent concerns, you might also try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
(References)
* Nimmo SM, Kennedy BW, Tullett WM, Blyth AS, Dougall JR. Drug-induced hyperthermia. Anaesthesia. 1993 Oct;48(10):892-5. doi: 10.1111/j.1365-2044.1993.tb07423.x. PMID: 7902026.
* Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006 Mar;63(3):332-9. doi: 10.1001/archpsyc.63.3.332. PMID: 16520440.
* March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. doi: 10.1001/archpsyc.64.10.1132. PMID: 17909125.
* Wang Z, Whiteside SPH, Sim L, Farah W, Morrow AS, Alsawas M, Barrionuevo P, Tello M, Asi N, Beuschel B, Daraz L, Almasri J, Zaiem F, Larrea-Mantilla L, Ponce OJ, LeBlanc A, Prokop LJ, Murad MH. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017 Nov 1;171(11):1049-1056. doi: 10.1001/jamapediatrics.2017.3036. PMID: 28859190; PMCID: PMC5710373.
* Wang Z, Whiteside S, Sim L, Farah W, Morrow A, Alsawas M, Moreno PB, Tello M, Asi N, Beuschel B, Daraz L, Almasri J, Zaiem F, Gunjal S, Mantilla LL, Ponte OP, LeBlanc A, Prokop LJ, Murad MH. 2017 Aug. PMID: 29360312.
* Himmerich H, Kan C, Au K, Treasure J. Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences. Pharmacol Ther. 2021 Jan;217:107667. doi: 10.1016/j.pharmthera.2020.107667. Epub 2020 Aug 25. PMID: 32858054.
* Boaden K, Tomlinson A, Cortese S, Cipriani A. Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment. Front Psychiatry. 2020;11:717. doi: 10.3389/fpsyt.2020.00717. Epub 2020 Sep 2. PMID: 32982805; PMCID: PMC7493620.
* Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2. Epub 2021 May 24. PMID: 34029378; PMCID: PMC8143444.
* Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, Kaye AD, Viswanath O, Urits I, Boyer AG, Cornett EM, Kaye AM. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Neurol Int. 2021 Aug 5;13(3):387-401. doi: 10.3390/neurolint13030038. Epub 2021 Aug 5. PMID: 34449705; PMCID: PMC8395812.
* Attia E, Walsh BT. Eating Disorders: A Review. JAMA. 2025 Apr 8;333(14):1242-1252. doi: 10.1001/jama.2025.0132. PMID: 40048192.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.